FindTrial
Sign In

Study of proteomics in blood of women with breast cancer

Clinical significance of Proteomics in liquid biopsy for Indian breast cancer women: An Exploratory study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036703
Enrollment
20
Registered
2021-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast

Interventions

None listed

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Treatment naïve biopsy proven breast cancer women Patients giving consent to participate in the study

Exclusion criteria

Exclusion criteria: pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
study of Differential proteomics in treatment naïve breast cancer women Timepoint: Baseline—

Secondary

MeasureTime frame
Differential proteomics after Neo-adjuvant chemotherapy in patients receiving the sameTimepoint: 10-14 weeks from baseline—

Countries

India

Contacts

Public ContactSuhani

All India Institute of Medical Sciences

drsuhani@gmail.com9810534358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026